Utah Medical Products (UTMD) Competitors $60.94 +3.45 (+6.00%) Closing price 04:00 PM EasternExtended Trading$60.98 +0.05 (+0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends. Is UTMD or CERS more profitable? Utah Medical Products has a net margin of 32.34% compared to Cerus' net margin of -9.81%. Utah Medical Products' return on equity of 10.55% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products32.34% 10.55% 10.13% Cerus -9.81%-33.77%-9.32% Do insiders and institutionals believe in UTMD or CERS? 69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 7.4% of Utah Medical Products shares are held by insiders. Comparatively, 5.6% of Cerus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, UTMD or CERS? Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$40.90M4.78$13.87M$3.7416.29Cerus$180.27M1.35-$20.92M-$0.10-12.65 Which has more risk and volatility, UTMD or CERS? Utah Medical Products has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Does the media refer more to UTMD or CERS? In the previous week, Utah Medical Products had 2 more articles in the media than Cerus. MarketBeat recorded 3 mentions for Utah Medical Products and 1 mentions for Cerus. Utah Medical Products' average media sentiment score of 0.56 beat Cerus' score of 0.00 indicating that Utah Medical Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Utah Medical Products 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate UTMD or CERS? Cerus has a consensus target price of $3.50, suggesting a potential upside of 176.68%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryUtah Medical Products beats Cerus on 10 of the 16 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$195.62M$10.85B$5.82B$9.74BDividend Yield2.11%1.88%3.84%4.09%P/E Ratio16.2920.9331.1525.97Price / Sales4.7829.96475.57123.18Price / Cash11.7324.6537.1558.38Price / Book1.663.509.116.39Net Income$13.87M$211.77M$3.26B$265.66M7 Day Performance9.84%4.44%2.11%1.98%1 Month Performance7.97%10.98%5.12%1.33%1 Year Performance-9.80%-8.36%31.25%21.15% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.4245 of 5 stars$60.94+6.0%N/A-14.7%$195.62M$40.90M16.29180Positive NewsDividend AnnouncementCERSCerus2.4031 of 5 stars$1.23-2.0%$3.50+185.7%-46.9%$234.83M$180.27M-12.25290Positive NewsOSUROraSure Technologies1.9067 of 5 stars$2.80-0.2%$3.00+7.3%-33.3%$204.43M$185.83M-4.17840ANIKAnika Therapeutics4.3644 of 5 stars$8.82+1.5%$18.00+104.1%-64.8%$127.18M$119.91M-2.13300WSTWest Pharmaceutical Services4.7311 of 5 stars$250.21+2.9%$320.71+28.2%-20.4%$17.96B$2.89B37.3910,600Positive NewsCOOCooper Companies3.9436 of 5 stars$74.03+0.7%$96.73+30.7%-22.0%$14.83B$3.90B35.9916,000News CoveragePositive NewsUpcoming EarningsALGNAlign Technology4.9657 of 5 stars$148.82+2.7%$215.00+44.5%-40.2%$10.73B$4.00B24.9720,945MMSIMerit Medical Systems4.4607 of 5 stars$86.77+0.7%$107.00+23.3%-5.8%$5.14B$1.43B44.057,400Positive NewsICUIICU Medical4.656 of 5 stars$124.37+1.1%$179.00+43.9%-22.6%$3.07B$2.38B-81.8715,000Positive NewsXRAYDENTSPLY SIRONA4.9928 of 5 stars$14.27+3.0%$18.64+30.6%-43.5%$2.85B$3.79B-3.0214,000Positive NewsHAEHaemonetics4.9592 of 5 stars$54.38+2.4%$85.18+56.6%-28.3%$2.62B$1.36B16.613,023Positive News Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Haemonetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access